Concepedia

Xianlu Qu

XQ

Statistics

Publications

6

Citations

426

H-Index

6

Active since

2008

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Xianlu Qu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and cell signaling.

Top concepts

Publications per year

2008–2012

6

Publications

6

Excitotoxic lesions restricted to the dorsal CA1 field of the hippocampus impair spatial memory and extinction learning in C57BL/6 mice

Gregory M. Dillon, Xianlu Qu, Jacob Marcus et al. · Neurobiology of Learning and Memory · 2008 · 108 citations

, , +9

MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor

Bo‐Sheng Pan, Grace K.Y. Chan, Mélissa Chénard et al. · Cancer Research · 2010 · 82 citations

, , +19

Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition

Amy D. Guertin, Melissa M. Martin, Brian S. Roberts et al. · Cancer Cell International · 2012 · 82 citations · Full text

Down‐regulation of the Notch pathway mediated by a γ‐secretase inhibitor induces anti‐tumour effects in mouse models of T‐cell leukaemia

Jennifer Tammam, C. Ware, Clay L. Efferson et al. · British Journal of Pharmacology · 2009 · 75 citations · Full text

Discovery of a 5<i>H</i>-Benzo[4,5]cyclohepta[1,2-<i>b</i>]pyridin-5-one (MK-2461) Inhibitor of c-Met Kinase for the Treatment of Cancer

Jason D. Katz, James P. Jewell, David Guérin et al. · Journal of Medicinal Chemistry · 2011 · 60 citations · Full text

, , +14

1–5 of 6